Vitamin C ( DrugBank: Vitamin C )

6 diseases

10. シャルコー・マリー・トゥース病

臨床試験数 : 41 / 薬物数 : 46 - (DrugBank : 9) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 15

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00484510 (ClinicalTrials.gov)	April 2007	8/6/2007	High Dose Ascorbic Acid Treatment of CMT1A	A Randomized, Placebo-controlled, Double Masked 120 Subject Futility Design Clinical Trial of Ascorb ...	Charcot-Marie-Tooth Disease, Type Ia	Drug: Ascorbic acid (Vitamin C);Drug: placebo	Wayne State University	Muscular Dystrophy Association;Charcot-Marie-Tooth Association	Completed	13 Years	70 Years	Both	110	Phase 2/Phase 3	United States

臨床試験数 : 4 / 薬物数 : 7 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 51

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900026719	2019-11-01	2019-10-19	Clinical study for combined application of vitamin Cand quercetin in the treatment of Cockayne's syn ...	Clinical study for combined application of vitamin Cand quercetin in the treatment of Cockayne's syn ...	Cockayne's syndrome	test group:Vitamin C and Quercetin;	The First Medical Center of PLA General Hospital	NULL	Pending	6	13	Both	test group:20;		China

臨床試験数 : 108 / 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-005460-42-ES (EUCTR)	07/07/2016	20/04/2016	Clinical trial to evaluate ascorbic acid (vitamin C) and tocopherol (vitamin E) in combination versu ...	Phase III clinical trial, double-blind, cross-way, to evaluate the safety and efficacy ascorbic acid ...	Fragile x syndrome MedDRA version: 19.0;Level: PT;Classification code 10017324;Term: Fragile X syndr ...	Product Name: Vitamin C INN or Proposed INN: Vitamin C Other descriptive name: ACIDUM ASCORBICUM D6 Pro ...	Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud	NULL	Not Recruiting			Female: no Male: yes		Phase 3	Spain
2	NCT01329770 (ClinicalTrials.gov)	December 2010	29/3/2011	Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome	Phase II Double-blind Randomized Placebo-controlled 1-way Crossover Trial to Investigate Safety and ...	Fragile X Syndrome	Dietary Supplement: Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E);Dietary Supplement: P ...	Yolanda de Diego Otero	NULL	Completed	6 Years	18 Years	Male	30	Phase 2	Spain

臨床試験数 : 51 / 薬物数 : 53 - (DrugBank : 22) / 標的遺伝子数 : 32 - 標的パスウェイ数 : 67

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00974025 (ClinicalTrials.gov)	June 2009	9/9/2009	Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients	Vitamin CMay Improve Endothelial Function and Exercise Capacity in Functional Single Ventricle Patie ...	Fontan Procedure;Hypoplastic Left Heart Syndrome;Tricuspid Atresia	Dietary Supplement: Vitamin C;Dietary Supplement: Placebo	University of Michigan	Griese-Hutchinson Champions for Children's Hearts Investigator Award	Completed	8 Years	25 Years	All	53	N/A	United States

臨床試験数 : 22 / 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00974025 (ClinicalTrials.gov)	June 2009	9/9/2009	Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients	Vitamin CMay Improve Endothelial Function and Exercise Capacity in Functional Single Ventricle Patie ...	Fontan Procedure;Hypoplastic Left Heart Syndrome;Tricuspid Atresia	Dietary Supplement: Vitamin C;Dietary Supplement: Placebo	University of Michigan	Griese-Hutchinson Champions for Children's Hearts Investigator Award	Completed	8 Years	25 Years	All	53	N/A	United States

臨床試験数 : 5 / 薬物数 : 6 - (DrugBank : 6) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 12

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00974025 (ClinicalTrials.gov)	June 2009	9/9/2009	Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients	Vitamin CMay Improve Endothelial Function and Exercise Capacity in Functional Single Ventricle Patie ...	Fontan Procedure;Hypoplastic Left Heart Syndrome;Tricuspid Atresia	Dietary Supplement: Vitamin C;Dietary Supplement: Placebo	University of Michigan	Griese-Hutchinson Champions for Children's Hearts Investigator Award	Completed	8 Years	25 Years	All	53	N/A	United States